US 9370519
Macrocyclic FLT3 kinase inhibitors
granted A61KA61K31/519A61K31/5377
Quick answer
US patent 9370519 (Macrocyclic FLT3 kinase inhibitors) held by Oncodesign SA expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oncodesign SA
- Grant date
- Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/519, A61K31/5377, A61P, A61P35/00